Refine your search
-
Authors
-
Item types
-
Topics
- *Antineoplastic Agents/tu [Therapeutic Use]
- *Carcinoma, Large Cell/dt [Drug Therapy]
- *Carcinoma, Neuroendocrine/dt [Drug Therapy]
- *Immune Checkpoint Inhibitors/tu [Therapeutic Use]
- *Lung Neoplasms/dt [Drug Therapy]
- *Sorafenib/tu [Therapeutic Use]
- *Thyroid Neoplasms/dt [Drug Therapy]
- Aged
- Antineoplastic Agents/ae [Adverse Effects]
- Carcinoma, Large Cell/im [Immunology]
- Carcinoma, Large Cell/mo [Mortality]
- Carcinoma, Large Cell/sc [Secondary]
- Carcinoma, Neuroendocrine/im [Immunology]
- Carcinoma, Neuroendocrine/mo [Mortality]
- Carcinoma, Neuroendocrine/sc [Secondary]
- District of Columbia
- Female
- Humans
- Immune Checkpoint Inhibitors/ae [Adverse Effects]
- Israel
- Show more
- Show less
-
Collections
-
Languages